Veeva Systems Inc.

VEEV

Veeva Systems provides cloud-based software solutions tailored for the global life sciences industry.
As a leader in this niche, the company is defined by its deep vertical specialization and focus on compliance and data management for pharmaceutical and biotech clients.

$182.01 -0.85 (-0.46%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy VEEV Today?

Analysis Overview for VEEV

Technical Perspective VEEV is in a pronounced downtrend, having dropped sharply over the past year and sitting near its 52-week low. Despite being technically oversold, the consistent negative momentum and heavy selling pressure raise near-term caution. The stock’s deep losses and underperformance versus the broader market signal persistent weakness.

Fundamental Strength Fundamentally, Veeva remains robust with strong revenue growth, expanding profit margins, and exceptional financial health. The company operates with minimal debt, ample cash reserves, and solid operational efficiency. These strengths suggest underlying business resilience despite recent share price deterioration.

Valuation & Risk Factors VEEV's valuation appears stretched, with elevated forward P/E and EV/EBITDA ratios implying high growth expectations. While high volatility and thin liquidity pose risks, the absence of short interest hints at less speculative pressure. Investors should weigh whether Veeva’s fundamentals can realistically validate its premium pricing over time.

Investment Recommendation

VEEV presents a compelling case for patient investors given its strong fundamentals, cash-rich balance sheet, and operational discipline. Although current technical momentum is weak and valuation remains lofty, the oversold position near yearly lows may offer an attractive entry point for long-term growth exposure. Considering the robust profitability and sector leadership, VEEV is a BUY for those comfortable with near-term volatility and confident in the company’s execution.

CTA Banner

VEEV 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis, here is the 12-month outlook for VEEV:

12-Month Outlook for VEEV

VEEV's outlook is characterized by a dichotomy between its strong underlying business and challenging market sentiment. The key near-term catalyst will be the company's ability to demonstrate that its robust fundamental growth—including revenue expansion and profit margins—can overcome the persistent negative technical momentum and justify its premium valuation. A return to favor with growth investors and any positive surprises in its cloud product cycles could serve as significant positive catalysts.

The primary risks include the stretched valuation failing to hold if growth moderates unexpectedly, and the potential for the current technical downtrend to persist, testing investor patience. High volatility remains a concern. Considering the oversold technicals and strong fundamentals, a conservative target price range for the next 12 months would be $200 - $240, implying a potential rebound as the disconnect between price and business performance narrows.

Wall Street Consensus

Most Wall Street analysts are optimistic about Veeva Systems Inc.'s 12-month outlook, with consensus target around $182.01, indicating expected upside potential.

Average Target
$182.01
35 analysts
Implied Upside
+0%
vs. current price
Analyst Count
35
covering this stock
Price Range
$146 - $237
Analyst target range
Buy Buy
24 (69%)
Hold Hold
9 (26%)
Sell Sell
2 (6%)

Bulls vs Bears: VEEV Investment Factors

Overall, VEEV has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • AI Product Launch: Veeva launched AI Agents to boost productivity in CRM and content review.
  • Clinical Trial Innovation: Company introduced eSource to streamline clinical trial data management.
  • Maintained Buy Rating: Stifel Nicolaus maintained a buy rating despite lowering price target.
  • High Investor Attention: Stock remains trending with significant investor interest and analysis.
Bearish Bearish
  • Analyst Downgrade: Keybanc downgraded Veeva to Sector Weight with no price target.
  • Price Target Cut: Stifel Nicolaus significantly reduced stock price target from $320 to $212.
  • Lack of Catalysts: Shares declined due to absence of positive news drivers.
  • Recent Share Slump: Stock price dropped, prompting reassessment of valuation concerns.
Reward Banner

VEEV Technical Analysis

VEEV has experienced substantial underperformance with a significant downtrend over the past year. The stock has undergone a pronounced decline, reflecting substantial negative momentum compared to the broader market.

The stock has posted deep losses over both the short and medium term, with a 1-month decline of -16.51% and a severe 3-month drop of -25.42%. Its relative strength versus the market of -29.51% confirms it is significantly underperforming the benchmark during this period.

Currently trading at $182.01, VEEV sits near the bottom of its 52-week range ($168.14 to $310.50), placing it in an oversold technical position. This proximity to the yearly low, coupled with the substantial -43.83% max drawdown, indicates the stock is under heavy selling pressure.

📊 Beta
1.08
1.08x market volatility
📉 Max Drawdown
-43.8%
Largest decline past year
📈 52-Week Range
$168-$310
Price range past year
💹 Annual Return
-18.8%
Cumulative gain past year
Period VEEV Return S&P 500
1m -16.5% -1.4%
3m -25.4% +4.1%
6m -35.9% +7.5%
1y -18.8% +15.4%
ytd -17.1% +0.4%

VEEV Fundamental Analysis

Revenue & Profitability Veeva demonstrates strong revenue growth with Q3 2026 revenue increasing to $811 million from $789 million in Q2, while maintaining robust profitability metrics. The company's net profit margin improved to 29.1% from 25.4% quarter-over-quarter, reflecting effective cost management. Operating margin also expanded significantly to 29.7%, indicating sustainable earnings quality.

Financial Health Veeva maintains exceptional financial health with a minimal debt ratio of just 1.1% and no long-term debt obligations. The company's strong liquidity position is evidenced by a current ratio of 7.5 and substantial cash reserves of $40.55 per share. Operating cash flow coverage ratios exceeding 2.1x demonstrate ample capacity to meet all financial obligations.

Operational Efficiency The company shows solid operational efficiency with a return on equity of 3.4% and return on capital employed of 3.4%, though asset turnover remains modest at 0.10. Veeva's cash conversion cycle of 26.5 days reflects efficient working capital management, while high fixed asset turnover of 5.8 indicates effective utilization of capital investments.

Quarterly Revenue
$0.8B
2025-10
Revenue YoY Growth
+16.0%
YoY Comparison
Gross Margin
75.4%
Latest Quarter
Free Cash Flow
$0.4B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is VEEV Overvalued?

VEEV appears overvalued based on traditional metrics. The forward P/E of 50.4 is significantly higher than the trailing P/E of 34.9, indicating elevated earnings expectations for future growth. However, the extremely high EV/EBITDA ratio of 176.7 suggests minimal current earnings power relative to its enterprise value, while a PEG ratio near 3.0 implies the stock's price may not be justified by its expected growth rate.

Without industry average data for direct comparison, the analysis relies on absolute valuation measures. The premium multiples suggest the market is pricing in substantial future growth and profitability improvements. Investors should carefully assess whether VEEV's growth trajectory can realistically support these elevated valuation levels in the absence of industry benchmark context.

PE
34.9x
Latest Quarter
vs. Historical
Near Low
5-Year PE Range 35×-117×
vs. Industry Avg
N/A
Industry PE ~N/A×
EV/EBITDA
176.7x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: This stock exhibits high volatility, indicated by a large beta value. Such fluctuations pose volatility risk, but also offer potential for substantial gains.

Other Risks: Notably, this stock has no observable short interest, which could otherwise suggest negative investor sentiment. However, the liquidity conditions might lack depth, potentially leading to rapid swings.

FAQs

Is VEEV a good stock to buy?

Neutral to slightly bearish for immediate buying due to valuation concerns and ongoing weak technical momentum. While Veeva maintains strong fundamentals, high profitability, and a debt-free balance sheet, the stock is expensive (forward P/E ~50) and has shown significant recent price deterioration. This might suit patient, long-term investors who believe the company's AI innovations can eventually justify its premium valuation—but short-term volatility risk remains high.

Is VEEV stock overvalued or undervalued?

Based on current metrics, VEEV appears overvalued. Its forward P/E of 50.4 and PEG ratio of nearly 3.0 are exceptionally high by absolute standards, suggesting the market is pricing in aggressive future growth that may not be sustainable. While Veeva demonstrates strong profitability (29% net margins) and pristine financial health (minimal debt), these premium valuation multiples indicate investors are paying a significant premium for expected growth that already appears fully priced into the stock.

What are the main risks of holding VEEV?

Based on the provided information, here are the key risks of holding VEEV stock:

1. High Volatility and Severe Price Decline Risk: The stock exhibits high beta-driven volatility and is in a pronounced downtrend, having lost over 25% in three months and trading near its 52-week low, indicating significant negative momentum and substantial loss potential. 2. Market and Competitive Risk: The stock's severe underperformance versus the broader market (-29.51% relative strength) suggests it is facing macroeconomic headwinds or competitive pressures that are negatively impacting its valuation relative to peers. 3. Low Asset Utilization Risk: Despite strong profitability, the company's low asset turnover ratio (0.10) indicates potential operational inefficiency or challenges in effectively scaling its asset base to generate sales.

What is the price forecast for VEEV in 2026?

Based on Veeva's strong fundamentals and growth trajectory, my forecast points to a target price range of $280-$340 for 2026. Key growth drivers include the continued adoption of its cloud-based Vault platform within the life sciences industry and expansion into adjacent markets. This outlook assumes sustained high revenue growth and profitability, driven by its leading niche position and sticky customer base. However, this forecast is highly sensitive to broader market sentiment towards growth stocks and the company's ability to maintain its premium valuation multiples against any potential growth deceleration.